Keyword Analysis & Research: bristol myers squibb

Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
bristol myers squibb0.560.869618620
bristol1.160.24719747
myers0.890.81978355
squibb0.140.23900966

Keyword Research: People who searched bristol myers squibb also searched

Keyword CPC PCC Volume Score
bristol myers squibb1.66141049
bristol-myers squibb oncology1.430.2700524
bristol myers squibb stock0.420.114485
bristol myers squibb careers1.980.769783
bristol myers squibb patient assistance form1.770.2926188
bristol myers squibb stock price0.880.952992
bristol myers squibb logo1.260.5859530
bristol myers squibb website0.681445633
bristol myers squibb eliquis0.370.9605286
bristol myers squibb company1.270.3819096
bristol myers squibb foundation0.60.1415611
bristol myers squibb patient assistance0.720.8678170
bristol myers squibb princeton nj0.940.1278191
bristol myers squibb summit nj0.350.7261994
bristol myers squibb investor relations0.390.3555497
bristol myers squibb seattle1.090.3855717
bristol-myers squibb jobs1.630.1392712
bristol myers squibb eliquis assistance form1.340.4122349
bristol myers squibb lawrenceville nj1.940.7184959
bristol myers squibb dividend history0.080.8460586
bristol myers squibb bms0.090.5757243
bristol myers squibb product list1.210.5358719
bristol myers squibb scandal0.980.198697
bristol myers squibb coupon for eliquis0.760.650839
bristol myers squibb eliquis coupons0.090.3602931

Search Results related to bristol myers squibb on Search Engine

  • Global Biopharmaceutical Company - Bristol Myers Squibb

    bms.com

    https://www.bms.com/

    WEBIf you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

    DA: 86 PA: 29 MOZ Rank: 51

  • About us - Bristol Myers Squibb

    bms.com

    https://www.bms.com/about-us.html

    WEBWe promote health equity and seek to improve the health outcomes of populations disproportionately affected by serious diseases. Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more.

    DA: 69 PA: 49 MOZ Rank: 90

  • Your Meaningful Career at Bristol Myers Squibb

    bms.com

    https://careers.bms.com/

    WEBDiscover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.

    DA: 38 PA: 67 MOZ Rank: 92

  • Products and medicines - Bristol Myers Squibb

    bms.com

    https://www.bms.com/patient-and-caregivers/our-medicines.html

    WEBBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.

    DA: 75 PA: 91 MOZ Rank: 42

  • Bristol-Myers Squibb Company (BMY) - Yahoo Finance

    yahoo.com

    https://finance.yahoo.com/quote/BMY/

    WEBBristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology ...

    DA: 15 PA: 1 MOZ Rank: 25

  • Bristol Myers Squibb - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Bristol_Myers_Squibb

    WEBThe Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

    DA: 98 PA: 42 MOZ Rank: 90

  • BMY | Bristol Myers Squibb Co. Stock Price & News - WSJ

    wsj.com

    https://www.wsj.com/market-data/quotes/BMY

    WEBPer-Share Earnings, Actuals and Estimates. View the latest Bristol Myers Squibb Co. (BMY) stock price, news, historical charts, analyst ratings and financial information from …

    DA: 3 PA: 88 MOZ Rank: 9

  • Bristol Myers Squibb - U.S. FDA Approves Bristol Myers Squibb’s …

    bms.com

    https://news.bms.com/news/corporate-financial/2022/US-FDA-Approves-Bristol-Myers-Squibbs-CAR-T-Cell-Therapy-Breyanzifor-Relapsed-or-Refractory-Large-B-cell-Lymphoma-After-One-Prior-Therapy/default.aspx

    WEBJun 24, 2022 · Bristol Myers Squibb: Creating a Better Future for People with Cancer. Bristol Myers Squibb is inspired by a single vision—transforming patients’ lives through science. The goal of the company’s cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility.

    DA: 6 PA: 25 MOZ Rank: 46

  • Bristol Myers Squibb Reports Fourth Quarter and Full-Year …

    bms.com

    https://news.bms.com/news/details/2023/Bristol-Myers-Squibb-Reports-Fourth-Quarter-and-Full-Year-Financial-Results-for-2022/default.aspx

    WEBFeb 2, 2023 · Bristol Myers Squibb posted revenues of $46.2 billion, consistent with the prior year, driven by in-line products (primarily Eliquis and Opdivo) and our new product portfolio (primarily Opdualag, Abecma and Reblozyl), offset by recent LOE products (primarily Revlimid) and foreign exchange. When adjusted for foreign exchange, …

    DA: 31 PA: 17 MOZ Rank: 77

  • Bristol Myers Squibb Strengthens and Diversifies Oncology …

    bms.com

    https://news.bms.com/news/details/2023/Bristol-Myers-Squibb-Strengthens-and-Diversifies-Oncology-Portfolio-With-Acquisition-of-Mirati-Therapeutics/default.aspx

    WEBOct 8, 2023 · Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a Best-in-Class KRAS G12C Inhibitor Approved by the U.S. FDA for the Treatment of Patients with Advanced Non-Small Cell Lung …

    DA: 81 PA: 87 MOZ Rank: 98